LSI's Select Alumni (Return) Presenters Announced Soon!
LSI USA '23
Confirmed Presenting Companies
Covellus is developing a modular catheter system that enables physicians to rapidly and easily adapt to various anatomy, disease state, procedural requirements and medical therapies. The Covellus Modular Architecture consists of two modules: a parent catheter than can have features of a conventional unitary catheter and a distal adapter that can feature a drug coated balloon, scoring or cutting balloon, aspiration solution and other possible combinations.
4D Biomaterials is developing and commercializing resorbable photocurable resins for a wide range of implantable medical device applications. The company's 4Degra biomaterials are 3D printed and tailored based on the needs of the implants, from softer grades for meshes, and films to harder formulations for pins, screws, and load-bearing bone regeneration scaffolds. 4D Biomaterials currently offers three grades of its T-Series material, from the flexible T15 to the most supportive T2500.
Definition Health develops a suite of digital health solutions to simplify the surgical pathway for patients and providers. The company has developed an "end-to-end" approach that offers virtual management, pre-operative assessment, and post-operative recovery monitoring for patients undergoing elective surgeries.
Sandeep Chauan, CEO & Co-Founder Definition Health
MedOnect is developing a novel therapeutic for the treatment of cancers of the blood. The company's MedOnect Life Treatment Vest uses electronic ultrasound to generate specific frequencies of electric signals that propagate through the body to disrupt cancerous cell function and facilitate the regeneration of healthy cells.
Allheartz is developing novel clinical AI-powered digital solutions to revolutionize home care in musculoskeletal (MSK) and sports health. The Software as a Medical Device (SaMD) platform innovated through the company's proprietary advanced computer vision applications turn an individual's smartphone into a medical-grade sensor. The platform is coupled with a remote HIPAA-compliant SaaS platform, to cut hospital costs while generating revenue through Remote Therapeutic Monitoring, simultaneously providing integrated, personalized, portable medicine that enables new highly scalable community-wide preventative care systems and value models.
Switfsure Innovations is addressing the challenges in caring for ventilated patients in critical care. The company's first product is being developed to improve oral care and reduce the incidence of ventilator-acquired pneumonia and its associated complications due to poor oral care.
ConnCons is developing smart medical consumables that will enable complete and automated control of infusions, dialysis, ventilation by software. The company's mission is to make these therapies safer, more efficient, and patiently friendly.
CorIT Medical is developing a solution targeting the most common patient complaint to ENTs - nasal obstruction. The company's CorIT device is a single-use surgical device for the reduction of inferior turbinates in patients with obstructed breathing.
Frond Medical is developing a breakthrough technology platform that allows highly precise positioning of diagnostic and therapeutic devices in real-time for interventional procedures. This improved accuracy translates into better clinical outcomes, faster procedures, reduced waste, minimized radiation exposure and contrast agent usage, and improved hospital financials.
Free Flow Medical is developing novel solutions for the treatment of chronic respiratory illnesses, including bronchitis, emphysema, and COPD. The company's lead products are the FreeFlow Coil for severe emphysema patients and the FreeFlow Valve System for COPD.
SafeHeals' Colovac is being developed to eliminate the need for diverting ostomies in patients undergoing colectomy. Colovac prevents the sequelae of anastomic leakage after colorectal surgery postoperative recovery during the critical 10-day postoperative healing stage.
Cern is developing a medical device for the treatment of bacterial and yeast vaginosis. The device uses low-level microbicidal light at specific wavelengths to induce oxidative stress at the DNA level in bacteria and yeast cells - inhibiting the ability of these cells to reproduce. The Cern Device represents a drug-free alternative for millions of women with vaginosis/vaginitis.
Sentante is developing a teleoperated/remote surgical robot for the performance of fully-robotic endovascular interventions. Artificial intelligence (AI) will enhance the capabilities of the system, enabling the performance of routine tasks during interventional cardiology procedures such as guidewire and catheter exchanges.
Edvardas Satkauskas, CEO Sentante / Inovatyvi Medicina
PherDal is making at-home fertility care affordable, safe, and effective. The company's sterile kits are designed to be easy-to-use and offer an alternative to expensive fertility treatments for families trying to conceive. PherDal is working with the FDA to become the first FDA-cleared at-home assisted reproduction kit. PherDal will provide the first over-the-counter fertility option to the 12.2 million women in the US looking for a safe fertility option to try before more invasive treatments.
Founded in 1866, TUV SUD is a partner of choice for safety, security and sustainability solutions. The company works as a partner in certification and testing services for manufacturers and suppliers of medical devices and in vitro diagnostics.
Martin Witte, Senior Director of Strategic Business Development TUV SUD
EnteroTrack has developed a simple and safe way to collect specimen to monitor the GI tract and test for GI diseases. The company's EnteroTracker is a quick, minimally invasive, office-based device to collect a liquid biopsy of mucosal content for specimen analysis.
THINK Surgical develops and commercializes robotic surgery systems for the orthopedics market. The company's TSolution One is indicated for total knee arthroplasty. The system is capable of fully automated bone preparation that is personalized and prepared utilizing proprietary planning tools to achieve optimal fit of the selected knee implant.
Virtonomy has developed an end-to-end digital twin and simulation solution to perform clinical development and testing in a virtual environment to accelerate development and reduce risks, expenses, and regulatory burdens. The company's virtual trial platform creates virtual patient cohorts based on real clinical data to reflect anatomical variability, demographic diversity, and pathological conditions.
Visapath's mission is to build the next-generation pathology lab that increases accuracy, efficiency, and quality across critical lab processes. The company's lead product, Sentinel, automatically measures and images tissue samples in under a second. The system rapidly generates a detailed report - reducing the turnaround time on specimen analysis.
GI Windows is developing a non-surgical approach to create anastomoses in the GI tract. The technology is designed to enable a durable, intestinal bypass to address chronic diseases, such as Type 2 Diabetes and Obesity, without the cost and invasiveness of surgical interventions.
ZygoFix develops and commercializes its zLOCK system, a proprietary technology that adds "bend-ability" to joints and provide natural stabilization. The technology is currently used to achieve spinal fusion and spinal stability without screws.
MACH32 is developing innovative medical devices to address global health problems. The company's IMSAFE device is a large-volume intramuscular autoinjector designed to deliver large quantities of medication in a safe and efficient manner. ACT (Aerosol Containment Tent) is a solution that creates a negative pressure environment zone around a patient's head, neck and shoulders to prevent the spread of infectious aerosol particles to uninfected individuals and healthcare providers.
MIMOSA has developed a tiny, hand-held device that democratizes the collection of tissue information in patients with peripheral vascular disease (PVD), wound care, diabetes, burns, and potential post-operative surgical complications. The device is capable of detecting tissue oximetry and temperature through the use of multispectral imaging, letting healthcare providers visualize beneath the skin, regardless of the patient's location.
HEPATIQ's software analyzes images from nuclear medicine scans to provide quantitative liver function. The company's software runs on local workstations, integrating with PACS to analyze images and prepare a report for review by the radiologist/nuclear medicine physician.
Histologics is committed to advancing the field of tissue sampling and care during colposcopic procedures. The company was established to improve histological sampling in women with abnormal cervical cancer screenings. At the core of the company's solutions is a proprietary medical fabric, Kylon, which is comprised of fenestrated loops that create unique hooks woven into nylon fabric. The fabric functions as a system to collect and contain tissue samples and can be applied to any device contour, shape, or surface.
CairnSurgical is developing an innovative tool to guide surgical interventions in patients with cancer. The company's Breast Cancer Locator (BCL) is a proprietary, patient-specific, 3D printed surgical guide intended to reduce positive margins during breast cancer tumor removal. The solution uses MRI data to create a personalized model that assist surgeons in localization and excision of tumors to reduce positive margins.
ViTAA is utilizing artificial intelligence to analyze computed tomography (CT) images to enhance the assessment of aneurysmal tissue. The AI solution, Regions of Aortic Weakness (RAW) is capable of color-coding and mapping abdominal aortic aneurysms based on the strength and weakness of the tissue, as well as identify calcium, thrombus, flow and strain to determine the risk of rupturing.
Randy Moore, Chief Medical Officer ViTAA Medical Solutions
Spinal Stabilization Technologies PerQdisc Replacement System is an innovative, less invasive solution for lumbar spine disc nucleus replacement for the treatment of chronic low back pain due to degenerative disc disease. PerQdisc replaces the physical space of the nucleus, recreates the biomechanical motion, and redistributes weight-bearing forces in an anatomical fashion.
Mark Novotny, President Spinal Stabilization Technologies
Smartlens has developed a device to enable "on the go" measurement of intraocular eye pressure. The company's flagship product, miLens, is an electronics-free device that provides seamless measurement capabilities to improve the early diagnosis of eye disease, certain neurological disorders, and cancers. In addition to the miLens product, the company's THERmic device applies micro-doses of personalized treatments for the treatment of glaucoma.
Imago is pioneering the development of Visual Intelligence (VI), a novel image analysis solution to support tissue visualization, characterization and analysis for diagnosis. The Software as a Service (SaaS) solution differentiates tissues based on their geometric properties in X-ray, PET, and MR images.
Theator has developed a real-time video monitoring system for the operating room and then analyzes data using artificial intelligence (AI). The platform automatically connects with the EHR to reveal unique insights and reduce variation in outcomes in the context of both patients and surgeons.
CoraVie Medical is developing a subcutaneous blood pressure monitor for patients with uncontrolled hypertension. The company's device is an implantable system intended to provide continuous, circadian blood pressure monitoring to inform treatment decisions and prevent the progression of cardiovascular disease.
CranioSense is developing a noninvasive solution to monitor intracranial pressure. The company's Intracranial Pressure (ICP) and Assessment Screening System (IPASS) is a nonsurgical alternative for measuring ICP and assisting in the management of traumatic brain injury (TBI).
Ryan Myers, Director of Business Development / Lead Engineer CranioSense
IRRAS is a commercial medtech company focused on developing innovative solutions to improve the management of post-operative fluids. The company's lead product, IRRAflow, is a next-generation intracranial fluid management system that features a dual lumen catheter and control unit to manage the drainage of excess fluid and intracranial pressure.
Advanced Bifurcation Systems is developing a solution to simplify and enhance the effectiveness of stenting of coronary arteries at bifurcations. The ABS platform ensures automatic alignment and perfect positioning of a bifurcating stent to evenly scaffold a bifurcation.
Mehran Khorsandi, Chairman & CEO Advanced Bifurcation Systems
Stimdia's pdSTIM system has been designed to electrically stimulate the phrenic nerves in a patient's neck to exercise the diaphragm during mechnical ventilation and minimize the impact of ventilation-induced diaphragmatic dysfunction. The temporary pacing stimulation is intended to support patients who have been ventilated for over 96 hours.
AccurKardia is a digital-first and software-only healthcare company focused on enabling a world in which a combination of smart devices, reliable and actionable data, and efficient clinical intervention can together improve medical outcomes and save lives. AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies
Syntr Health Technologies is a developer of an automated microfat processing system to enable natural healing and rejuvenation. The company's technology, which can be used in a physician office, is currently FDA cleared for use in over 12 surgical specialities. The company seeks to commercialize first in the aesthetics and plastic surgery, with future commercialization in wound care, general surgery, orthopedic & arthroscopic surgery, and dermatology.
Kneevoice has designed a platform technology to capture the noise generated by the knee to evaluate cartilage damage and diagnose osteoarthritis. The platform consists of wearable knee sensors that records the sounds generated by the knee. This data is collected an analyzed by a neural network algorithm and generates a score evaluating the status of the cartilage.
Arga Medtech is developing a next-generation solution for the treatment of cardiac arrhythmia and atrial fibrillation. The company's Coherent Sine-burst Electroporation (CSE) uses a proprietary puled-field ablation (PFA) generator and catheter to offer a single-shot device capable of producing linear and focal lesions safer, more efficiently and faster than existing technologies used to treat cardiac arrhythmias today.
Linshom (“to breathe”) is first to deliver an Operating Room quality respiratory profile to the patient bedside and home for continuous, predictive respiratory monitoring (CPRM). Our FDA cleared device provides a full respiratory profile delivered continuously and in real time to predict and intercept respiratory decline before an emergency develops.
Graphene core technology designed to decode brain signals into medical solutions in the field of neuroelectronic therapies with the objective to restore patients' quality of life in those affected with brain-origin disorders. The company is developing a minimally invasive neural interface which will initially serve patients with epilepsy and Parkinson's disease.
DirectSync Surgical is developing a proprietary technology to imitate the natural healing properties of bone using minute electrical stimulation. The company leverages the human body's mechanical biofeedback system to design disruptive "smart implants" that heal bone using natural bone forming pathways.
S-Alpha Therapeutics is a digital therapeutics company developing platform technologies to enable digital therapies for different chronic diseases. The company's lead product, SAT-001, is preparing for testing in clinical studies for the treatment of eye disease. Other indications under development include neurology, oncology, and gastroenterology.
CorNeat Vision has developed a proprietary platform for developing nondegradable, biomimetic biomaterials to treat diseases. The company's EverMAtrix material is a 100% synthetic, nondegradable porous material that mimics the micro-structure of the extracellular matric (ECM). CorNeat's technology has been applied to products for dental and ophthalmic surgery.
Adaptix is developing an innovative, miniaturized flat panel X-ray source and associated software to transform existing X-ray systems into Digital Tomosynthesis systems to expand patient access to low-dose 3D imaging.
BURL Concepts' SONAS is a portable, battery-powered ultrasound system that enables non-invasive brain perfusion assessment at the point-of-care. SONAS is used in combination with microbubble contrast agents to evaluate unilateral and bi-lateral cerebral perfusion.
InVera Medical is developing a catheter-based therapy for chronic venous disease. The device uses non-thermal energy to disrupts the inner vessel lining, resulting in natural scarring and vessel closure that diverts blood flow away from diseased vessels.
AIRAmed develops AI-based software solutions to improve medical care for neurodegenerative diseases. The company's lead product, AIRAscore, uses neural networks to analyze and quantify global and regional brain volumes from MRI images to detect deviations from the normal ageing process of the brain.
Mirai Medical ePORE therapy is a unique precision therapy platform that targets and destroy tumor tissue without harming surrounding healthy tissue. The minimally invasive technology delivers pulsed electrical fields that create pores in the cell membrane of tumor cells, catalyzing cellular death. Mirai's technology has been developed for external (skin) and internal (endoscopic) tumor treatment.
Lazzaro Medical has developed a minimally invasive surgery for the treatment of Tracheobronchomalacia (TBM), a degenerative disease that causes the complete, or near-complete, collapse of the airway due to cartilage breakdown in the trachea. The LM Scaffold System restores the patency of the trachea, improving breathing through a simple procedure conducted via a robotic system. The company is pursuing a platform approach to the treatment of TBM and other pipeline indications with the development of a diagnostic tool to simplify diagnosis and an endotracheal tube to improve the efficiency of respiratory surgeries.
Versono is developing an intravascular ultrasonic platform to improve the crossing of severe occlusions in the peripheral vasculature. The device will prepare a working lumen to support endovascular therapy in patients with chronic total occlusions (CTOs) and critical limb ischemia (CLI).
Azalea Vision is developing a solution for patients with conditions and disorders that increase sensitivity to light. The company's solution actively adapts and manages within a personalized contact lens. The lens will also be capable of compensating for refractive errors of the eye, such as astigmatism and myopia.
LimFlow is developing a minimally invasive solution to bypass blocked peripheral arteries, restoring blood flow to the foot. The LimFlow Percutaneous Deep Vein Arterialization System is a new treatment for patients with Chronic Limb-Threatening Ischemia (CLTI) that will reduce amputations, promote wound healing, and resolve pain.
Trukera Medical is building a portfolio of products to address unmet needs in eye care for patients and providers. The company's ScoutPro osmolarity system is a handheld osmolarity testing device for the detection of toxic hyperosmolarity, a condition which damages corneal cells and drives refractive instability.
Acorai is developing a non-invasive monitoring solution to measure pulmonary artery pressure. The handheld device utilizes a unique combination of acoustic, electrocardiographic, pressure, seismic and visual sensors to collect robust data to be analyzed using a machine learning engine to evaluate heart failure progression. The company's solution is an alternative to the current standard procedure, which involves right heart catheterization performed in a catheterization lab to evaluate heart functionality.
FeelTect's Tight Alright is a connect-health platform that provides data-driven, targeted, and consistent compression therapy for the treatment of venous leg ulcers. The solution employs a point-of-care wearable pressure sensing device that optimizes traditional compression therapy to reduce healing time, frequencies in healthcare visits, and costs to treat.
Visura manufacturers the world's first, FDA-cleared, disposable camera, the TEECAD System, that seamlessly connects to a transesophageal echocardiogram (TEE) echo probe, providing physicians real-time visualization for more efficient and effective probe placement for safer intubation.
CAPS Medical is developing a solution to treat a wide range of solid tumors using Non-thermal Atmospheric Plasma (NTAP). This minimally invasive procedure selectively destroys cancer cells without damaging the surrounding healthy tissue.
Endolumik is developing a fluorescence-guided esophagogastric calibration system (i.e. a bougie) for use in bariatric and gastric surgery. The Endolumik System uses near-infrared lighting with an intra-gastric stent to improve visualization, precision and consistency in laparoscopic and robotic surgical procedures.
Portal Instruments is developing a needle-free technology for the delivery of biologics. The handheld device is capable of delivering small and large molecules through subcutaneous, intradermal and intramuscular tissue layers. Portal's technology will improve the patient experience, providing greater comfort during drug administration.
Mosie is simplifying home insemination for couple's seeking to become pregnant. Mosie is a syringe designed to improve intravaginal insemination (IVI) and deliver sperm near the cervical opening and improving pregnancy odds. The Mosie syringe has been designed to overcome the limitations of standard syringes used for IVI, with a modified barrel and angular opening to safely deliver sperm.
CAIRA is developing software for advanced joint replacement. The software utilizes radar technology to improve navigation during manual and robotic surgery. The company's first product is a navigation system for use during knee replacement surgery.
BioT's cloud platform simplifies the creation of a connected care ecosystem. The platform is self-service and requires no coding to connect medical devices, patient management portals, caregivers, and EHRs in an integrated space.
Pretika MedTech is reimagining outpatient and inpatient care with AI-powered Connected Wound Care technology. The company's non-invasive, embedded medical device and wireless digital care cloud platform provides on demand or continuous imaging, sensor and data analytics for physicians and nursing teams to monitor post-surgery, wound and disease healing remotely or in-person without having to remove the surgical dressings, bandages, wraps or casts.
Gyder Surgical's Gyder Hip System is a non-invasive, pin-less navigation solution for total hip replacement. The system is an open platform that can be used with a surgeon's preferred implant system, reduces radiation exposure by not requiring CT or X-ray imaging, and seamlessly integrates into existing workflows due to the system's simple set-up and quick calibration.
Neuronoff is developing an injectable electrode platform that is an adaptive, minimally invasive technology that transforms complex neuromodulation procedures into simple outpatient procedures. The Injectrode technology enables the electrical stimulation of hard to reach nerves and tissues using an 18 ga needle and self-anchor to prevent lead migration.
Locate Bio is working to solve some of the most complex degenerative and infectious diseases that affect the muscular skeletal system. Locate utilises Programmed Drug Release to re-align the bioavailability of existing drugs with the underlying biological need. This bio-optimisation step has demonstrated break through improvements in performance in preclinical testing.
Locate Bio’s lead product, LDGraft, is entering human clinical studies next year, for the treatment of chronic lower back pain caused by degenerative disc disease. CognitOss Gel is in developed to overcome bacterial biofilm infections around non-viable tissue and orthopaedic implants.
Cold cap therapy is a commonly used solution to prevent hair loss in patients undergoing chemotherapy. Cooler Heads is developing a novel cold cap system for cancer patients that has been designed to be easier to use and more affordable than existing solutions.
Harmonic Bionics is a robotics company developing exoskeleton solutions to improve and rehabilitate movement impairments due to neurological and musculoskeletal disorders. The company's lead product, Harmony SHR, is a bilateral, upper-extremity exoskeleton designed to optimize upper-extremity rehabilitation.
Titan Medical is focused on enhancing robotic assisted surgery (RAS) using innovative technology through a single access point. The Enos™ system includes multi-articulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. Titan intends to initially pursue gynecological surgical indications with the Enos system.
Lumeda is developing DigiLum, a light dosimetry solution that utilizes artificial intelligence (AI) and photonics to activate a photosensitizer drug and deliver photodynamic therapy for the treatment of Non-Small Cell Lung Cancer (NSCLC). The DigiLum system enables a fast and simplified treatment that is automated to ensure ease-of-use, repeatability, and efficacy.
Ultrasound AI is empowering mothers and providers with accurate information regarding the wellbeing of mothers and their babies. The company's AI was trained using hundreds of thousands of ultrasound images from thousands of patients to be able to forecast and predict preterm birth. The technology empowers both patients and providers to prepare for and reduce preterm birth.
Noninvasix is using optoacoustic technology to monitor critically ill patients in the hospital. The company is developing a non-invasive device monitor patients for sepsis and septic shock in real-time. The device will enable healthcare providers to rapidly diagnose, monitor, and respond to these life-threatening conditions in patients.
Solenic Medical is developing a non-invasive medical device that utilizes alternating magnetic fields to eradicate biofilms that form on implants. The company's platform uses external magnetic coils to destroy infective biofilms on the surface of knee and hi replacement implants, as well as plates and rods for trauma related procedures. Solenic's solution is being developed to replace the expensive and risky two-step revision surgery, which is the current standard of care for chronic infections on medical implants.
Nutromics is pioneering Continuous Molecular Monitoring (CMM), a real-time biomarker monitoring platform that offers molecular patient data. The technology integrates into a wearable smart patch that continuously captures and transmits data to mobile and web-based applications for easy integration with hospital and consumer health software.
SpinTech MRI is dedicated to addressing clinical and operational challenges in magnetic resonance imaging. The company's STAGE (strategically acquired gradient echo) solution reduces MRI acquisition and processing time, improving patient throughput and workflow efficiency. The solution integrates with virtually all MRI systems and manufacturers.
Otolith is developing a wearable device for the treatment of vertigo. The device delivers a precise level of mechanical stimulation to the acceleration sensors of the inner ear. The therapeutic vibration masks vertiginous signals from the vestibular system to alleviate vertigo symptoms.
Fluid Biomed is a VC-backed pre-clinical medical device start-up that has developed the world’s first bio-resorbable stent to cure brain aneurysms. Our innovative polymer technology allows physicians the versatility of treating a wider variety of aneurysms more safely and efficiently. Backed by years of laboratory research, a strong IP and tech transfer position, and contract manufacturing partners, the company is opening a $10M Series A round to launch human clinical trials.
MY01 has developed a device to continuously monitor and manage acute compartment syndrome in muscles. The MY01 device is a sterile, single-use device that quickly measures muscle pressure following orthopedic surgery for trauma.
Formus Labs has developed a software-as-a-service (SaaS) solution for use in orthopedic surgeries. The company's solution is an automated 3D planner for joint replacement surgeries that combines AI and computational biomechanics to created patient-specific surgical plans. The initial software solution is focused on hip replacement surgery.
NextSense is a developer of a real-world monitoring solution to obtain insights into brain health. The company's platform collects longitudinal electroencephalogram (EEG) data from biosensing earbuds that can be worn throughout the day and night. Data collected will enable new insights and personalize treatments for neurological conditions and general mental well-being.
Since 1982, Leonhardt Ventures has been a leader in developing medical devices and biologics. The company is focused on organ regeneration & recovery innovations based on the convergence of bioelectrics & biologics. Leonhardt works within Brain, Cancer, Cosmetic and Personal Care, Major Organ Regeneration, and Heart & Cardiovascular. Over 600,000 patients have been treated with Leonhardt inventions to date.
Howard Leonhardt, Executive Chairman & CEO Leonhardt Ventures
NeoPredix is utilizing digital health solutions and intelligent algorithms to support maternal, neonatal, and perinatal care. The company's prediction software will support clinical decision makers, allowing them to personalize and optimize patient care based on deep medical data and science.
Synova Life Sciencesis a biotechnology company that has developed a proprietary methodology and system for processing fat cells into autologous stem cells. Using Synova's approach, clinicians and researchers are able to obtain greater yields of stem cells 30 times faster than the current gold standard for stem cell harvesting.
Sense Biodetection develops and commercializes an easy-to-use, affordable, disposable molecular diagnostic testing platform. The company's products are portable and quickly obtain PCR-based results to truly bring diagnostic testing to the point-of-care.
Wearable Artificial Organs is developing truly portable solutions for use in patients with End Stage Renal Disease (ESRD). The company has currently prototyped two wearable device, a cordless continuous renal replacement therapy (CRRT) system and a wearable artificial kidney.
TibaRay is developing a next-generation radiation therapy technology, called PHASER, to deliver radiation treatment with unprecedented accuracy and exquisite shaping by ultrafast imaging. The PHASER system verifies tumor and organ positioning and "freezes" motion as treatment is delivered.
Kurve brings a breakthrough approach to treat CNS disorders like Mild Cognitive Impairment, Alzheimer's, and Parkinson's. Kurve has completed Phases I, II, IIB and is Phase III ready in MCI. Kurve successfully delivers our proprietary medications through the blood brain barrier with a next generation drug delivery technology. Kurve brings revolutionary new treatments for CNS disorders through technology and drugs that modify the disease, creating breakthrough successes in medication effectiveness and quality of life. With demonstrated clinical efficacy, Kurve is changing the landscape of CNS therapies.
NovaResp is developing technology to improve the prediction of respiratory events in patients using positive airway pressure (PAP) machines. The company's platform uses artificial intelligence and machine learning to monitor respiration and prevent detrimental episodes of apnea.
Hamed Hanafi, President & Director of R&D NovaResp Technologies
Facible Biodiagnostics is leading the diagnostic testing revolution through our mission to provide hospital-grade diagnostic tests to everyone, everywhere. Our patented Q-LAAD technology allows us to develop diagnostics tests without the tradeoff between speed, accuracy, and ease of use inherent in legacy diagnostic testing technologies. Join us to learn more about the diagnostic testing revolution.
Endoluxe is a world-class wireless endoscopic video imaging organization launching its industry design award-winning Endoluxe EVS Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption, and improving patient outcomes through better therapy application utilizing advanced AI/ML functionality. Endoluxe is positioned to disrupt the market as a vendor agnostic platform that allows clinicians to utilize their existing investment in traditional scopes and supporting devices, utilizing a portable, integrated, and feature-rich platform at 1/10th the cost of legacy products. More information can be found at Endoluxe.com.
PrecisionOS develops software solutions that leverage extended reality to enhance surgical performance while accelerating the safe use of medical devices. The solutions are part of the digital surgery ecosystem helping to improve surgical outcomes through enhanced experiential pre-operative planning and training.
Molecular breast imaging (MBI) technology to more accurately diagnose early-stage breast cancer in women with dense breast tissue. The Eve Clear Scan platform utilizes gamma cameras and intravenously injected cancer tracers to identify rapidly growing cancer cells that can potentially evade detection with traditional mammogram technology.
Wearable patch that utilizes ultrasound to continuously monitor cardiac output and performance. The Pulsify Patch is intended to offer new insights into patients' cardiovascular health that can't be captured using traditional catheter and ultrasound transducer-based approaches.
Developing solutions to simplify critical care in neurocritical patients. BrainSpace is committed to improving the way brain pressure is managed in patients recovering from stroke, traumatic brain injury, and neurosurgery.
Berkshire Biomedical Corporation is developing drug delivery devices by pioneering the use of biometric technologies, combined with cloud-based and physician-enabled remote management systems to provide accurate personalized medication delivery to the authenticated Intended User. The Company’s lead product under development, the Computerized Oral Prescription Administration (COPATM) System, is an authenticated Intended User automated oral liquid dispensing system designed to deliver controlled and non-controlled liquid oral medications to only the Intended User upon confirmation of fingerprint and dentition biometric identification.
John Timberlake, President & CEO Berkshire Biomedical
The Levita Magnetic Surgical System is an innovative technological platform that utilizes magnetic retraction designed to grasp and retract tissue and organs in laparoscopic cholecystectomy procedures to facilitate access and visualization of the surgical site. Levita Magnetic has implemented this technology into a robotic platform to assist in the performance of laparoscopic surgeries.
A predictive health company developing the next generation of medical devices with smart sensors and artificial intelligence. The company's Accuryn system transforms a Foley catheter into a real-time sensor of urine output, intra-abdominal pressure, and core body temperature to monitor risk of acute kidney injury.
In the future, measuring things inside the body will be as easy as taking your blood pressure. Having precise data and measurements in real time is becoming more and more critical for the doctor and care giver while performing medical procedures and diagnosis. Cephasonics is leading the way in using AI and ultrasound data to non-invasively automatically detect, identify, characterize and measure things in the body without the need for a trained professional. Today, Cephasonics is the only company to provide a complete FDA-ready HW & SW OEM ultrasound platform that provides unfettered access to ultrasound data and enables AI for clinical applications that support medical procedures and diagnosis with precise data about key aspects of a medical procedure in real time.
Randall Whiting, Chief Operating Officer / Member BOD Cephasonics Ultrasound Solutions
NanoHive Medical is a pioneer and innovator in 3D printed spinal interbody fusion implants and instrumentation. NanoHive Medical's proprietary, biomimetic Soft Titanium technology clearly distinguishes their products in the $1.5B spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provides surgeons and their patients with the ideal features that lead to consistently strong fusion constructs and efficacious clinical experiences.
SIVA Therapeutics mission is to develop minimally invasive devices for cancer treatment. To achieve this goal, the company is developing a nanotechnology platform that utilizes targeted hyperthemia to heat and destroy solid tumors and spare healthy tissues.
IntraOp Medical is dedicated to transforming cancer treatment using electron-beam Intraoperative Radiation Therapy (IORT). The company's flagship product, Mobetron, is a mobile, self-shielded LINAC system to deliver radiation during cancer surgery.
Zeto's electroencephalogram (EEG) is an FDA-cleared alternative to traditional EEG setups. The company has developed a wearable headset that is wireless, eliminates the need for preparation (e.g. gel application), and fully integrates with cloud data systems for real-time data viewing and management.
The company is developing the MIRA® (Miniaturized In vivo Robotic Assistant) Platform, a first-of-its-kind miniaturized surgical robotic support device, focusing first on colon resection, with follow-on specialty robots for additional potential applications.
Predictive, personalized computational modeling and simulation solutions for structural heart interventions that empower medical device manufacturers to bring superior products faster to the market and enable physicians to improve clinical outcomes.
Retia makes advanced hemodynamic monitors using the patented Multi-Beat Analysis MBA™ algorithm to guide care for high-risk surgical and ICU patients. Using the data from our monitor, clinicians implement proven protocols that reduce acute kidney injuries, myocardial injuries and other costly complications.
Anavasi Diagnostics is a molecular diagnostic company using miniaturized RT-LAMP technology to provide lab-quality molecular diagnostic results in the CLIA-waived / POC environment, and eventually, the home -- in 30 minutes, on average.
Nelson Patterson, CEO Anavasi Diagnostics
PercuSense’s continuous multi-analyte sensor system combines monitoring of multiple biosensors with knowledge of how diseases and illness progress to intelligently and proactively recommend treatment.
Long-term, non-thermal resolution of atrial fibrillation. AtriAN Medical is developing an innovative solution for the treatment of AF that utilizes micro-Pulsed Electric Field (mPEF). This non-thermal approach targets hyperactive cell structures on the outside of the heart and disrupts the errent electrical signals that are responsible for AF, while sparing healthy tissue.